RxDoctor Payments DataLook up a doctor →

Oscar Parodi Ortiz de Villate, MD

Pulmonary Disease · Warren, MINPI 1699985689

Payments from drug & device makers

$1,092,972in general payments, 2019–2025

Across 290 payments — averaging $3768.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$759K
  • GSK$149K
  • Boehringer Ingelheim$133K
  • AstraZeneca$18K
  • Sanofi$17K
  • Boehringer Ingelheim International GmbH$15K
  • plus $1K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,092,972 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Medicare billing

Part B allowed, 2024
$174,837
Medicare patients
373
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →